Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 31   

Articles published

AZN 4,483.50 +16.50 (0.37%)
price chart
Apple, Google, Oracle, AstraZeneca: Intellectual Property
AstraZeneca Plc, the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
Boards wake up to a shareholder spring
Two weeks ago David Brennan, chief executive of AstraZeneca, bowed to pressure from the pharmaceutical group's top shareholders and stepped down at the annual meeting.
Expand your mindfulness
... to have impressed hard-nosed companies such as Google (which has invited mindfulness gurus to speak at the Googleplex), General Mills, PricewaterhouseCoopers, Deutsche Bank, Procter & Gamble, AstraZeneca, Apple, Credit Suisse, KPMG, Innocent, ...
US to Seek New Uses for Abandoned Drugs
But researchers and the university or hospital involved will get patent rights for any new uses of the compound, according to the NIH and drug-company officials.
Moss quits after pay revolt at Aviva
Mr Moss is the third high-profile UK chief executive to fall victim to investor anger, following the departures of Sly Bailey from Trinity Mirror and David Brennan from AstraZeneca. But the terms of Mr Moss's exit drew criticism after Aviva last week ...
UK Pay Protests Oust Aviva Chief  Wall Street Journal
Aviva Chief Executive Officer Andrew Moss to Leave  Bloomberg
Risk and reward: The world's most dangerous business locations
Convenience is not a priority when it comes to commodities. Drilling and exploration often takes place in war-torn, risky environments and none more so than Somalia.
Where can investors find shelter from the volatility storm?
Similarly, AstraZeneca fell by 665p but it is yielding a very attractive 6.5pc. Mr McDermott tipped Neil Woodford's Invesco Perpetual High Income fund but said equities were not the only route to income.
Torch bearers of tomorrow grab flame of inspiration
KuDOS was acquired by AstraZeneca in 2005. He has also led a new spin-out company - MISSION Therapeutics Ltd. Jack LangSerial entrepreneur and business angel, and ... He was a co-founder of CSR plc which listed on the London Stock Exchange in March ...
Drug-Defying Germs From India Speed Post-Antibiotic Era
... during the past decade, says Karen Bush, a microbiologist at Indiana University in Bloomington. She led teams that developed five bacteria-fighting drugs beginning in the 1970s in laboratories that are now part of AstraZeneca Plc, Bristol-Myers ...
Last month AstraZeneca PLC agreed to acquire Ardea, and Ardea's shares are up about 89% year-to-date. For 2012 Mr. Nadeau's favorite pick is Dynavax Technologies Corp.